10x Genomics, Inc. (TXG)

NASDAQ: TXG · Real-Time Price · USD

65.05

+5.77 (9.73%)

Nov 9, 2026, 4:00 PM EST - Market closed

10x Genomics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	8,556	2,064	1,738	6,615	4,171	16,640
Market Cap Growth	409.49%	18.74%	-73.72%	58.59%	-74.93%	9.21%
Enterprise Value	8,056	1,669	1,426	6,357	3,815	16,120
Last Close Price	65.05	16.31	14.36	55.96	36.44	148.96

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	13.83	3.21	2.85	10.69	8.08	33.92
PB Ratio	10.21	2.59	2.45	8.93	5.18	20.35
P/TBV Ratio	11.08	2.83	2.52	9.19	5.36	21.13
P/FCF Ratio	91.25	15.86	-	-	-	-
P/OCF Ratio	85.82	15.17	260.86	-	-	-

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	13.02	2.60	2.34	10.27	7.39	32.86
EV/FCF Ratio	85.92	12.83	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.09	0.11	0.12	0.13	0.12	0.10
Debt / FCF Ratio	0.81	0.65	-	-	-	-
Net Debt / Equity Ratio	-0.60	-0.55	-0.44	-0.40	-0.42	-0.62
Net Debt / EBITDA Ratio	18.86	6.85	1.97	1.79	2.42	15.90
Net Debt / FCF Ratio	-5.33	-3.37	54.25	4.60	2.03	4.12
Asset Turnover	0.59	0.66	0.65	0.62	0.50	0.50
Inventory Turnover	2.74	2.85	2.50	2.70	1.70	1.65
Quick Ratio	4.52	3.95	4.10	3.96	4.08	6.10
Current Ratio	5.12	4.46	4.97	4.69	4.85	6.77
Return on Equity (ROE)	-8.27%	-5.78%	-25.17%	-32.98%	-20.45%	-7.48%
Return on Assets (ROA)	-3.93%	-6.40%	-12.84%	-12.52%	-9.99%	-3.40%
Return on Capital Employed (ROCE)	-7.10%	-11.30%	-24.20%	-23.80%	-18.20%	-5.80%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-0.80%	-2.11%	-10.51%	-3.86%	-3.98%	-0.35%
FCF Yield	1.10%	6.30%	-0.33%	-0.96%	-3.96%	-0.74%
Buyback Yield / Dilution	-4.52%	-3.57%	-2.80%	-2.90%	-3.18%	-9.09%

SEC Filings: 10-K · 10-Q